Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions

NCT05721729 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Postbariatric Hypoglycemia

Interventions

DRUG: Mizagliflozin
DRUG: Placebo

Sponsor

Vogenx, Inc.